SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hims & Hers Shares Climb on Potential Peptide Sales

Hims & Hers shares rose amid potential sales of some unapproved peptides.

HIMS
SquawkNews Desk 1 updates Updated Oct 28, 2026, 05:41 PM UTC

Story updates

05:41:39 PM UTC
SquawkNews
BUZZ-Hims & Hers 股价因可能销售某些未经批准的肽类产品而上涨 10月28日 - ** Hims & Hers Health（HIMS.N）股价上涨5%，至29.35美元，此前美国卫生部

Related stories

Reliance Industries Q2 Profit May Top Rs 21,000 Crore Reliance Industries is expected to report September-quarter profit above Rs 21,000 crore, with refining and Jio cited as earnings drivers. The company is scheduled to announce resu M impact | EQUITY | Oct 30, 2026, 04:11 AM UTC Australian Energy Stocks Reach One-Week High as Oil Rises Australian energy stocks reached a one-week high as supply concerns lifted oil prices. M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC Nasdaq 100 futures fall 2%; S&P 500 futures down almost 1% M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC U.S. Stock Futures Fall as Intel and Amazon Earnings Weigh At 11:44 p.m. EDT, Dow futures fell 0.17%, S&P 500 futures fell 0.95% and Nasdaq-100 futures fell more than 2% after disappointing earnings from Intel and Amazon. M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC Janome to Buy Back Up to 5.98% of Shares L impact | EQUITY | Oct 30, 2026, 04:02 AM UTC Asian session market picture: S&P 500 -0.94%, Nasdaq 100 -2.06%; USD/JPY -0.15%, WTI +1.18%, 1810 leads volume Asian session market picture. US index futures: S and P futures is down 0.94 percent, Nasdaq futures is down 2.06 percent, Dow futures is down 0.19 percent and Russell futures is d M impact | EQUITY | Oct 30, 2026, 04:00 AM UTC